Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years
Clinical trial NCT00802464 · COMPLETED
Trial details
- NCT number
- NCT00802464
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-12
- Primary completion
- 2010-07-02
- Enrollment
- 410
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.